https://www.cochranelibrary.com/web/cochrane/content?templateType=full&urlTitle=/cdsr/doi/10.1002/14651858.CD015395.pub3&doi=10.1002/14651858.CD015395.pub3&type=cdsr&contentLanguage=&highlightAbstract=paxlovid
Lots of criticism levelled at Starpharma for not conducting human placebo trials. But in January we got a great significant human covid treatment trial. I think this report by Cochrane Org about Paxlovid changes perspective and one really questions how TGA meekly followed FDA and gave TA temporary approval to Pfizer. Cochrane seems very unimpressed
If Viraleze 7 day treatment is competing with Paxlovid - who wins
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.18M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 12.0¢ | 12.0¢ | $2.279K | 18.99K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 215514 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 21006 | 2 |
View Market Depth
| Last trade - 12.51pm 15/09/2025 (20 minute delay) ? |
| SPL (ASX) Chart |